SEP 2023

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/1504856

Contents of this Issue


Page 81 of 82

*Trabecular meshwork (trabeculotomy), Schlemm's canal (canaloplasty), and collector channels (canaloplasty). 1 Klabe K, et al. 2021 Jul 20. Clin Ophthalmol. 15:3121-3129. INDICATIONS FOR USE: The OMNI ® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm's canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. CONTRAINDICATIONS: Do not use the OMNI Surgical System in any situations where the iridocorneal angle is compromised or has been damaged (e.g., from trauma or surgery), since it may not be possible to visualize the angle or to properly pass the microcatheter. Do not use the OMNI Surgical System in patients with angle recession; neovascular glaucoma; chronic angle closure; narrow-angle glaucoma; traumatic or malignant glaucoma; or narrow inlet canals with plateau iris. Do not use the OMNI Surgical System in quadrants with previous MIGS implants. Please refer to the full Instructions For Use, available at omnisurgical.com/IFU, for warnings, precautions, and adverse event information. ©2023 Sight Sciences, Inc. OMNI is a registered trademark of Sight Sciences, Inc. 01/2023 OM-2514-US.v2 The OMNI ® Surgical System from Sight Sciences is the first and only glaucoma device indicated for canaloplasty followed by trabeculotomy that allows you to: PERFORM Two implant-free procedures in both standalone MIGS and combo cataract TARGET Three points of resistance intended to lower IOP* DELIVER Sustained long-term IOP reduction 1 RELY On an established reimbursement code ONLY OMNI CAN Visit OMNIsurgical.com to discover the benefits Ergo-Series now available in the United States. Scan to schedule a demo.

Articles in this issue

Links on this page

Archives of this issue

view archives of Eyeworld - SEP 2023